Skip to content
healthcare.dev

Terazosin

NDC 71610-503, Terazosin Hydrochloride, capsule, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-503
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE5 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
71610-503-607161005036090 CAPSULE in 1 BOTTLE (71610-503-60)
71610-503-8071610050380180 CAPSULE in 1 BOTTLE (71610-503-80)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/81d5422c-ff57-4f6d-927c-5de4dd7e1169

Use it

Look up 71610-503 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.